file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
401 | NORMAL | 13 | 72 | 344 |
402 | TOLEROGENIC | 6 | 117 | 344 |
403 | PRESENTATION | 5 | 12 | 343 |
404 | SIGNIFICANCE | 11 | 64 | 343 |
405 | PREPARATION | 14 | 55 | 342 |
406 | CALCINEURIN | 12 | 9 | 341 |
407 | AXONAL | 3 | 41 | 340 |
408 | HISTORY | 18 | 17 | 339 |
409 | PULMONARY | 10 | 26 | 339 |
410 | SPONTANEOUS | 18 | 115 | 337 |
411 | USED | 16 | 61 | 337 |
412 | MOFETIL | 8 | 13 | 336 |
413 | MYCOPHENOLATE | 8 | 13 | 336 |
414 | TOPICAL | 10 | 15 | 336 |
415 | DISORDERS | 12 | 26 | 334 |
416 | MARROW-DERIVED | 7 | 74 | 334 |
417 | ALG | 9 | 70 | 333 |
418 | DECADE | 5 | 26 | 332 |
419 | VIVO | 10 | 41 | 332 |
420 | ANTITHYMOCYTE | 22 | 42 | 331 |
421 | DOG | 10 | 88 | 331 |
422 | ERA | 10 | 25 | 331 |
423 | PROPAGATION | 5 | 91 | 329 |
424 | INTERACTION | 8 | 15 | 328 |
425 | APPLICATION | 13 | 40 | 327 |
426 | PROCEDURE | 3 | 20 | 327 |
427 | REACTION | 23 | 75 | 327 |
428 | FK506-BINDING | 3 | 22 | 325 |
429 | PROCUREMENT | 4 | 19 | 325 |
430 | TISSUES | 8 | 95 | 325 |
# | Word | Recs | TLCS | TGCS |
431 | TRIALS | 6 | 77 | 325 |
432 | GLOMERULAR | 9 | 29 | 324 |
433 | HISTORICAL | 7 | 142 | 323 |
434 | ANERGY | 3 | 57 | 322 |
435 | ASSESSMENT | 14 | 67 | 319 |
436 | LATE | 11 | 61 | 319 |
437 | SIMULTANEOUS | 22 | 84 | 318 |
438 | IMMUNOSUPPRESSANTS | 11 | 33 | 317 |
439 | INFECTION | 19 | 7 | 317 |
440 | INFECTIONS | 8 | 18 | 317 |
441 | URINARY | 11 | 23 | 317 |
442 | FLEXIBLE | 1 | 19 | 316 |
443 | EXOGENOUS | 2 | 16 | 314 |
444 | PERSPECTIVES | 12 | 48 | 313 |
445 | DIFFERENT | 13 | 135 | 312 |
446 | INITIAL | 10 | 20 | 312 |
447 | RENAL-ALLOGRAFTS | 14 | 49 | 310 |
448 | POSSIBLE | 11 | 42 | 309 |
449 | CAUSES | 8 | 33 | 308 |
450 | RABBIT | 17 | 44 | 307 |
451 | MAINTENANCE | 11 | 95 | 306 |
452 | CAUSE | 6 | 131 | 304 |
453 | CYTOCHROME-P-450 | 2 | 23 | 304 |
454 | EPITHELIAL | 6 | 9 | 303 |
455 | ANTIGENS | 16 | 25 | 302 |
456 | MACROPHAGE | 5 | 111 | 302 |
457 | SPECIFIC | 13 | 36 | 301 |
458 | BIOTRANSFORMATION | 1 | 23 | 299 |
459 | EFFICIENT | 1 | 10 | 298 |
460 | LIQUID-CHROMATOGRAPHIC | 3 | 9 | 297 |
# | Word | Recs | TLCS | TGCS |
461 | BABOON-TO-HUMAN | 1 | 32 | 296 |
462 | SYNGENEIC | 6 | 48 | 296 |
463 | MOUSE-LIVER | 3 | 82 | 295 |
464 | MOLECULAR-CLONING | 1 | 20 | 294 |
465 | OVEREXPRESSION | 1 | 20 | 294 |
466 | RESISTANCE | 5 | 39 | 294 |
467 | REGULATORS | 3 | 30 | 293 |
468 | CONSIDERATIONS | 13 | 31 | 291 |
469 | DIAGNOSIS | 12 | 42 | 291 |
470 | GRANULOCYTE | 4 | 113 | 291 |
471 | ISOLATION | 9 | 59 | 291 |
472 | SPONTANEOUSLY | 6 | 98 | 291 |
473 | CD86 | 2 | 47 | 288 |
474 | GROWTH | 11 | 81 | 288 |
475 | PHARMACOLOGY | 5 | 30 | 288 |
476 | FEMALE | 4 | 175 | 284 |
477 | SIMPLIFIED | 5 | 12 | 283 |
478 | CTLA4-IG | 1 | 16 | 281 |
479 | GRAFTING | 7 | 58 | 281 |
480 | HUMANS | 9 | 42 | 279 |
481 | LEUKOCYTE | 17 | 80 | 279 |
482 | MEASUREMENT | 7 | 66 | 278 |
483 | PROPERTIES | 13 | 53 | 278 |
484 | REPERFUSION | 4 | 10 | 278 |
485 | POST-TRANSPLANT | 8 | 14 | 277 |
486 | LEWIS | 6 | 118 | 276 |
487 | DIFFERENTIAL | 8 | 24 | 275 |
488 | INVOLVEMENT | 6 | 20 | 275 |
489 | VARIABLE | 7 | 154 | 275 |
490 | EPISODES | 9 | 63 | 274 |
# | Word | Recs | TLCS | TGCS |
491 | TRANSDUCTION | 4 | 23 | 274 |
492 | NONREACTIVITY | 1 | 171 | 273 |
493 | COMPLETE | 6 | 31 | 272 |
494 | BIOPSIES | 9 | 21 | 269 |
495 | ACCEPTED | 7 | 88 | 267 |
496 | DELAYED | 7 | 51 | 267 |
497 | LANGERHANS | 9 | 29 | 267 |
498 | PATHWAY | 7 | 17 | 267 |
499 | SEVERE | 11 | 45 | 266 |
500 | THORACIC | 4 | 127 | 265 |
501 | GLOMERULONEPHRITIS | 8 | 38 | 263 |
502 | PERSISTENCE | 11 | 109 | 263 |
503 | LEADING | 3 | 30 | 262 |
504 | CYTOCHROME | 4 | 24 | 261 |
505 | DONOR-CELL | 2 | 155 | 261 |
506 | INHIBIT | 6 | 7 | 261 |
507 | LYMPHOPROLIFERATIVE | 11 | 16 | 261 |
508 | MONKEY | 4 | 100 | 261 |
509 | PASSENGER | 12 | 120 | 261 |
510 | CORRELATION | 8 | 41 | 260 |
511 | PROBE | 4 | 22 | 260 |
512 | UPPER | 5 | 21 | 260 |
513 | USEFULNESS | 1 | 10 | 259 |
514 | CORRELATES | 10 | 47 | 258 |
515 | CONCENTRATIONS | 10 | 52 | 257 |
516 | CONCEPTS | 11 | 28 | 256 |
517 | INHIBITOR | 6 | 15 | 255 |
518 | MALIGNANCY | 2 | 33 | 255 |
519 | ORAL | 13 | 28 | 255 |
520 | ISOLATED | 6 | 19 | 254 |
# | Word | Recs | TLCS | TGCS |
521 | LYMPH | 5 | 10 | 252 |
522 | PERSPECTIVE | 12 | 117 | 252 |
523 | INCREASED | 15 | 22 | 251 |
524 | PRIMATES | 12 | 44 | 251 |
525 | METHOTREXATE | 4 | 7 | 250 |
526 | PROBES | 3 | 7 | 250 |
527 | TOLERANT | 10 | 81 | 250 |
528 | COSTIMULATORY | 3 | 40 | 247 |
529 | UNRESPONSIVENESS | 9 | 64 | 247 |
530 | TARGET | 4 | 3 | 246 |
531 | BENEFICIAL | 4 | 8 | 245 |
532 | CYTOMEGALOVIRUS | 7 | 10 | 245 |
533 | PRELIMINARY | 10 | 27 | 245 |
534 | HEPATOTOXICITY | 1 | 27 | 244 |
535 | CD80 | 1 | 40 | 243 |
536 | MOLECULE-DEFICIENT | 1 | 40 | 243 |
537 | NONIMMUNOSUPPRESSED | 1 | 40 | 243 |
538 | METASTATIC | 2 | 2 | 242 |
539 | PROLONGED | 16 | 60 | 242 |
540 | TRENDS | 7 | 131 | 242 |
541 | ALLOANTIGEN-SPECIFIC | 2 | 42 | 240 |
542 | DOSAGE | 7 | 24 | 240 |
543 | GENE | 13 | 13 | 240 |
544 | LOCALIZATION | 8 | 177 | 240 |
545 | CYCLOSPORINE-INDUCED | 6 | 19 | 239 |
546 | PROGRESS | 11 | 34 | 239 |
547 | SEQUENTIAL | 9 | 33 | 239 |
548 | VISCERAL | 2 | 41 | 239 |
549 | CONTROL | 7 | 23 | 238 |
550 | EMERGING | 1 | 7 | 238 |
# | Word | Recs | TLCS | TGCS |
551 | POLYMERASE | 16 | 108 | 238 |
552 | RELEASE | 7 | 21 | 238 |
553 | TRANSCRIPTIONAL | 4 | 18 | 238 |
554 | ABO | 7 | 31 | 237 |
555 | BOWEL | 31 | 36 | 237 |
556 | DECREASED | 5 | 6 | 237 |
557 | HYPERSENSITIVITY | 5 | 19 | 236 |
558 | LIVER-TRANSPLANTS | 4 | 46 | 236 |
559 | POTENT | 8 | 39 | 236 |
560 | KIDNEYS | 17 | 34 | 235 |
561 | VIEW | 4 | 135 | 235 |
562 | APPROACH | 12 | 51 | 234 |
563 | ATTRIBUTED | 1 | 8 | 231 |
564 | RECONSTRUCTION | 5 | 37 | 231 |
565 | SYNERGISTIC | 8 | 16 | 231 |
566 | COLUMN | 3 | 16 | 230 |
567 | DIAGNOSTIC | 8 | 13 | 230 |
568 | HLA | 9 | 52 | 230 |
569 | INVIVO | 11 | 9 | 230 |
570 | ARTERY | 6 | 14 | 229 |
571 | DUCT | 7 | 33 | 229 |
572 | EXENTERATION | 1 | 21 | 228 |
573 | FREQUENCY | 7 | 16 | 228 |
574 | SYSTEM | 13 | 18 | 228 |
575 | DETERMINING | 1 | 72 | 227 |
576 | INDICATIONS | 7 | 10 | 227 |
577 | SHORT-AND | 1 | 72 | 227 |
578 | LOSS | 6 | 18 | 226 |
579 | PLUS | 6 | 49 | 225 |
580 | REGULATORY | 14 | 32 | 224 |
# | Word | Recs | TLCS | TGCS |
581 | SURGICAL | 14 | 12 | 222 |
582 | DEVELOPING | 6 | 21 | 221 |
583 | FOLLOWED | 3 | 23 | 221 |
584 | MORPHOLOGICAL | 4 | 23 | 221 |
585 | PARENTHOOD | 2 | 5 | 221 |
586 | SIROLIMUS | 5 | 13 | 221 |
587 | APPROACHES | 9 | 4 | 220 |
588 | CLINICALLY | 6 | 14 | 220 |
589 | PAST | 10 | 7 | 220 |
590 | QUANTITATIVE | 17 | 8 | 220 |
591 | RECOVERY | 7 | 29 | 220 |
592 | PERMITTED | 2 | 133 | 219 |
593 | UPDATE | 7 | 10 | 219 |
594 | BLOCKADE | 6 | 15 | 218 |
595 | LESIONS | 8 | 11 | 218 |
596 | SEROLOGIC | 5 | 57 | 218 |
597 | SPLENECTOMY | 12 | 20 | 218 |
598 | SECRETION | 5 | 5 | 217 |
599 | FLOW | 14 | 59 | 216 |
600 | THYMECTOMY | 6 | 43 | 216 |